William von Almen, MD
Gynecology · New Orleans, LANPI 1831123876
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,050 of the $16,940 with a category attached, or 77.0%. 33 manufacturers reported payments, led by Organon at 41.4% of the total. Reporting peaked in 2019 at $5,944 and has fallen 98.1% since, to $111 in 2025. Among gynecology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $121.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$7K
- Merck$6K
- Applied Medical Resources Corporation$991
- AbbVie$691
- Amgen$359
- Biohaven Pharmaceuticals, Inc.$273
- plus $1K from 27 others
What the payments were for
- Consulting fees$250%
- Speaking & faculty fees$13,05077%
- Travel & lodging$9576%
- Food & beverage$2,85617%
- Education$520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 13 | $7,009 |
| Merck | 12 | $6,248 |
| Applied Medical Resources Corporation | 6 | $991 |
| AbbVie | 16 | $691 |
| Amgen | 7 | $359 |
| Biohaven Pharmaceuticals, Inc. | 14 | $273 |
| Astellas Pharma US Inc | 8 | $165 |
| Sumitomo Pharma America, Inc. | 9 | $162 |
| Pfizer | 9 | $160 |
| Hologic Sales And Service, LLC | 5 | $110 |
| Millicent US Inc | 6 | $102 |
| Coopersurgical, Inc. | 1 | $95 |
| Myovant Sciences Inc. | 5 | $85 |
| Bayer | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $45 |
| Scynexis, Inc. | 2 | $44 |
| Therapeuticsmd, Inc. | 3 | $41 |
| Intuitive Surgical | 1 | $40 |
| Davol Inc. | 1 | $24 |
| Shield Therapeutics Inc | 1 | $23 |
| AMAG Pharmaceuticals, Inc. | 2 | $22 |
| Convatec Inc. | 1 | $21 |
| Teleflex LLC | 1 | $20 |
| Eisai Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Exeltis, USA Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
| Duchesnay USA Incorporated | 1 | $15 |
| Radius Health, Inc. | 1 | $14 |
| Urovant Sciences Inc | 1 | $14 |
| Lupin Inc. | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$13,000
- GelPOINT V-Path$835
- Orilissa$355
- EVENITY$125
- Prolia$125
How this compares
$16,940 in reported general payments places this provider in the 90th percentile of 37 gynecology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremproEstrogen,con/M-Progest Acet | 31 | $7,975 |
| PremarinEstrogens, Conjugated | 13 | $5,652 |
| Estradiol | 174 | $4,654 |
| Estradiol (Once Weekly)Estradiol | 22 | $2,553 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 26 | $2,075 |
| Estradiol (Twice Weekly)Estradiol | 14 | $1,967 |
| Raloxifene Hcl | 57 | $1,341 |
| ValacyclovirValacyclovir Hcl | 14 | $933 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 28 | $907 |
| ProgesteroneProgesterone, Micronized | 17 | $557 |
| Alendronate Sodium | 41 | $375 |
| Clobetasol Propionate | 18 | $359 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 19 | $261 |
| Medroxyprogesterone Acetate | 20 | $186 |
| Clonazepam | 15 | $175 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPrempro, Premarin | $160 | $13,62744 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 37 gynecology providers in Louisiana.
Other gynecology in New Orleans
- Donna WatersNew Orleans$3K
- Jack JacobNew Orleans$2K
- Tiandra Singleton WattersNew Orleans$198
- Leonard WeatherShreveport$89K
- May ThomasseeLafayette$50K
- Albert TydingsCovington$5K
- Alison StewartMetairie$4K
- Stacey ScheibMetairie$4K
- Dwan MabryHammond$3K
- Margie KahnMetairie$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.